12m
Hosted on MSNADMA Biologics Gears Up to Report Q4 Earnings: What's in the Cards?We expect investors to focus on the sales performance of ADMA Biologics’ ADMA portfolio of marketed products and other ...
27m
Hosted on MSNExpanding Diabetes Business Supports ABT Stock, FX Issues StayAbbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025. Yet, the international business environment continues to be challenging. The stock carries a Zacks ...
LYV's fourth-quarter 2024 results are likely to reflect the impacts of strong ticket sales, robust sponsorship growth and a rise in average per-fan spending.
CELH's Q4 results are likely to reflect the impacts of internal and external challenges, while growth endeavors should offer ...
Fiverr (FVRR) delivered earnings and revenue surprises of -7.25% and 2.38%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
NEM is expected to have benefited from higher gold prices and strong production volumes in the fourth quarter.
Arista Networks (ANET) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Deckers (DECK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
DDOG's premium valuation multiples and stiff competitive pressures suggest investors that they can wait for a better entry ...
The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, that makes building a winning portfolio easier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results